Brevan Howard Capital Management’s Agilent Technologies A Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.07M Buy
35,679
+26,528
+290% +$3.37M 0.04% 315
2025
Q4
$1.25M Buy
9,151
+5,458
+148% +$784K 0.01% 668
2025
Q3
$474K Sell
3,693
-391
-10% -$47.2K ﹤0.01% 1319
2025
Q2
$482K Buy
+4,084
New +$453K ﹤0.01% 1370
2024
Q1
Sell
-6,651
Closed -$925K 962
2023
Q4
$925K Buy
6,651
+378
+6% +$45K 0.01% 261
2023
Q3
$701K Hold
6,273
0.01% 124
2023
Q2
$754K Hold
6,273
0.02% 107
2023
Q1
$868K Hold
6,273
0.02% 87
2022
Q4
$939K Hold
6,273
0.03% 59
2022
Q3
$762K Buy
6,273
+4,100
+189% +$527K 0.03% 55
2022
Q2
$258K Hold
2,173
0.01% 45
2022
Q1
$288K Buy
+2,173
New +$299K 0.02% 30

Other funds holding A

Brevan Howard Capital Management's A Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Agilent Technologies (A) stake by 290% in Q1 2026, buying an estimated $3.37M and bringing the position to 35,679 shares worth $4.07M. The position accounts for 0.04% of the portfolio, ranked #315.

Brevan Howard Capital Management first reported a position in A in Q1 2022 and has held it in 12 quarters since. 1,068 funds tracked by Wall St. Rank hold A as of Q1 2026.

  • Brevan Howard Capital Management held 35,679 shares of Agilent Technologies worth $4.07M as of Q1 2026.
  • Brevan Howard Capital Management bought 26,528 Agilent Technologies shares in Q1 2026, an estimated $3.37M.
  • Agilent Technologies made up 0.04% of Brevan Howard Capital Management's portfolio in Q1 2026, its #315 holding.
  • Brevan Howard Capital Management first reported a position in Agilent Technologies in Q1 2022 and has held it in 12 quarters since.
  • 1,068 funds tracked by Wall St. Rank held Agilent Technologies as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.